Siva Sundeep Koppolu
Psychiatry · North Little Rock, ARNPI 1316493943
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Avanir Pharmaceuticals, Inc. at 35.1% of the total. Reporting peaked in 2024 at $1,991 and has fallen 52.2% since, to $953 in 2025. Among psychiatry clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $51.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanir Pharmaceuticals, Inc.$2K
- Johnson & Johnson$1K
- AbbVie$478
- Teva Pharmaceuticals USA, Inc.$314
- Amgen$278
- Otsuka America Pharmaceutical, Inc.$252
- plus $592 from 10 others
What the payments were for
- Travel & lodging$2,26444%
- Food & beverage$2,76253%
- Education$1683%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanir Pharmaceuticals, Inc. | 14 | $1,821 |
| Johnson & Johnson | 22 | $1,459 |
| AbbVie | 25 | $478 |
| Teva Pharmaceuticals USA, Inc. | 8 | $314 |
| Amgen | 2 | $278 |
| Otsuka America Pharmaceutical, Inc. | 10 | $252 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $223 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Harmony Biosciences LLC | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Janssen Scientific Affairs, LLC | 1 | $43 |
| Neurocrine Biosciences, Inc. | 2 | $43 |
| Nevro Corp. | 1 | $37 |
| Lundbeck LLC | 1 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,194 in reported general payments places this provider in the 90th percentile of 235 psychiatry providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 26 | $57,063 |
| Bupropion XlBupropion Hcl | 97 | $3,084 |
| Prazosin Hcl | 14 | $885 |
| Buspirone Hcl | 50 | $830 |
| Duloxetine Hcl | 50 | $756 |
| Mirtazapine | 37 | $637 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $550 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $528 |
| Methylphenidate Hcl | 14 | $523 |
| Aripiprazole | 19 | $378 |
| Divalproex Sodium ErDivalproex Sodium | 15 | $372 |
| Sertraline Hcl | 44 | $357 |
| Trazodone Hcl | 56 | $319 |
| Gabapentin | 22 | $249 |
| Clonazepam | 44 | $241 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $1,459 | $57,06326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 235 psychiatry providers in Arkansas.
Other psychiatry in North Little Rock
- Joann KirchnerNorth Little Rock$39K
- Jane KangNorth Little Rock$1K
- Leslie SmithLittle Rock$766K
- Tad TillemansLittle Rock$656K
- Steven KoryElm Springs$628K
- Ronald WautersSearcy$204K
- Herman ClementsSearcy$187K
- Randal ScholmaLowell$111K
- Kyle JohnsonMorrilton$69K
- Paul WylieLittle Rock$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.